MARGetuximab Or Trastuzumab (MARGOT)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer|HER2-positive Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Pertuzumab|DRUG: Margetuximab|DRUG: Trastuzumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: MacroGenics|Translational Breast Cancer Research Consortium